AstraZeneca

• Approval of AstraZeneca’s Evusheld COVID treatment in Canada is ‘good news,’ experts say

  AstraZeneca Canada said in a press release that its Evusheld has received a Notice of Compliance from Health Canada to treat COVID-19 for those aged 12 or older.

  Health

  Oct 19, 2022
  
• Canada to throw away more than half of expired AstraZeneca vaccine doses

  Canada also has yet to explain how it plans to manage millions of doses of both Novavax and Medicago vaccines that the country bought.

  Health

  Jul 5, 2022
  
• Advertisement
• J&J’s COVID-19 vaccine restricted by FDA due to rare but serious blood clot risk

  U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.

  Health

  May 5, 2022
• Advertisement
• COVID-19: Booster shot uptake rises in Sask. as province adds 829 new cases, 14 deaths

  There were 829 new COVID-19 cases confirmed last week in Saskatchewan with 231 cases found in the Saskatoon zone and 141 in the Regina zone.

  Health

  Apr 28, 2022
• Health Canada OKs AstraZeneca’s Evusheld drug for COVID-19 prevention

  AstraZeneca's Evusheld contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.

  Canada

  Apr 14, 2022
• AstraZeneca forecasts 2022 growth even as COVID revenue wanes

  While sales of COVID-19 products are expected to decline by a low-to-mid 20s percentage this year, Astrazeneca forecast overall revenues to rise by a high teens percentage.

  Consumer

  Feb 10, 2022
• AstraZeneca says it is working on an Omicron vaccine with Oxford

  "Together with Oxford University, we have taken preliminary steps in producing an Omicron variant vaccine, in case it is needed," a spokesperson for the company said.

  World

  Dec 21, 2021
• FDA approves 1st COVID-19 antibody drug intended for long-term prevention

  People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs.

  World

  Dec 8, 2021
• Advertisement
• Omicron variant: AstraZeneca exploring impact on vaccine, antibody cocktail

  AstraZeneca said that it had developed a vaccine platform to respond quickly to new variants with Oxford University, where its vaccine was created.

  World

  Nov 26, 2021
• Advertisement
• AstraZeneca says COVID-19 antibody drug 83% effective over six months

  AstraZeneca's treatment is given in one go, as two sequential shots in the arm.

  Health

  Nov 18, 2021